IFNAR1 blockade with anifrolumab in an infant with SAVI-associated interstitial lung disease: Rapid CD169 suppression and clinical remission after therapy-refractory JAK inhibition
Lipek, T.; Hohmann, T.; Rittich, E.; Birkenhauer, N.; Seiffert, S.; Boldt, A.; Muller-Nedebock, A.; Jamra, R.; Grafe, D.; May, D.; Wiederanders, A.; Dunst, F.; Klemann, C.; Prenzel, F.
Share
Save